Related references
Note: Only part of the references are listed.A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age
Jeanny Kwon et al.
JOURNAL OF BREAST CANCER (2017)
Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer
G. Pruneri et al.
ANNALS OF ONCOLOGY (2016)
Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer
Jacqueline Tsai et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00
Giancarlo Pruneri et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups
Mustapha Abubakar et al.
BREAST CANCER RESEARCH (2016)
Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
A. S. Coates et al.
ANNALS OF ONCOLOGY (2015)
Ki67-no evidence for its use in node-positive breast cancer
Fabrice Andre et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S. Loi et al.
ANNALS OF ONCOLOGY (2014)
Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer
Fadia J. A. Gujam et al.
BMC CANCER (2014)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial†
C. Denkert et al.
ANNALS OF ONCOLOGY (2013)
Triple negative breast cancer: Clinical characteristics in the different histological subtypes
Geertje Dreyer et al.
BREAST (2013)
Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome
Emilia Montagna et al.
CLINICAL BREAST CANCER (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Triple-negative breast cancer in the older population
P. Boyle
ANNALS OF ONCOLOGY (2012)
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer
Elisabetta Munzone et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The prognostic significance of lymphovascular invasion in invasive breast carcinoma
Emad A. Rakha et al.
CANCER (2012)
Clinicopathologic Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network
Nancy U. Lin et al.
CANCER (2012)
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Mohammed A. Aleskandarany et al.
BREAST CANCER RESEARCH (2012)
Clinical relevance of TNM staging system according to breast cancer subtypes
Y. H. Park et al.
ANNALS OF ONCOLOGY (2011)
Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society
Sei Hyun Ahn et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer
Leonel F. Hernandez-Aya et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Triple negative breast cancer - prognostic factors and survival
Tanja Ovcaricek et al.
RADIOLOGY AND ONCOLOGY (2011)
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
Bhumsuk Keam et al.
BREAST CANCER RESEARCH (2011)
Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival
Jung Ah Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Ki67 in breast cancer: prognostic and predictive potential
Rinat Yerushalmi et al.
LANCET ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF ONCOLOGY PRACTICE (2010)
Breast cancer prognostic classification in the molecular era: the role of histological grade
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2010)
Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status
William D. Foulkes et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Rethinking TNM: A Breast Cancer Classification to Guide to Treatment and Facilitate Research
Umberto Veronesi et al.
BREAST JOURNAL (2009)
Lymph Node Ratio as an Alternative to pN Staging in Node-Positive Breast Cancer
Vincent Vinh-Hung et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sites of Distant Recurrence and Clinical Outcomes in Patients With Metastatic Triple-negative Breast Cancer High Incidence of Central Nervous System Metastases
Nancy U. Lin et al.
CANCER (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Share Paper
